BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31813105)

  • 1. Diverse roles of arrest defective 1 in cancer development.
    Chaudhary P; Ha E; Vo TTL; Seo JH
    Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
    Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
    Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
    Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.
    Lee D; Jang MK; Seo JH; Ryu SH; Kim JA; Chung YH
    Exp Mol Med; 2018 Jul; 50(7):1-12. PubMed ID: 30054466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
    Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
    Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrest defective 1 regulates the oxidative stress response in human cells and mice by acetylating methionine sulfoxide reductase A.
    Shin SH; Yoon H; Chun YS; Shin HW; Lee MN; Oh GT; Park JW
    Cell Death Dis; 2014 Oct; 5(10):e1490. PubMed ID: 25341044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARD1/NAA10 acetylation in prostate cancer.
    Kuhns KJ; Zhang G; Wang Z; Liu W
    Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAA10 as a New Prognostic Marker for Cancer Progression.
    Kim SM; Ha E; Kim J; Cho C; Shin SJ; Seo JH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARD1 contributes to IKKβ-mediated breast cancer tumorigenesis.
    Zhang Y; Zhou H; Tao Y; Liu X; Yuan Z; Nie C
    Cell Death Dis; 2018 Aug; 9(9):860. PubMed ID: 30154412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.
    Lozada EM; Andrysik Z; Yin M; Redilla N; Rice K; Stambrook PJ
    Oncotarget; 2016 Apr; 7(15):20425-39. PubMed ID: 26967250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
    Magin RS; March ZM; Marmorstein R
    J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear translocation of hARD1 contributes to proper cell cycle progression.
    Park JH; Seo JH; Wee HJ; Vo TT; Lee EJ; Choi H; Cha JH; Ahn BJ; Shin MW; Bae SJ; Kim KW
    PLoS One; 2014; 9(8):e105185. PubMed ID: 25133627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy.
    Qian X; Li X; Cai Q; Zhang C; Yu Q; Jiang Y; Lee JH; Hawke D; Wang Y; Xia Y; Zheng Y; Jiang BH; Liu DX; Jiang T; Lu Z
    Mol Cell; 2017 Mar; 65(5):917-931.e6. PubMed ID: 28238651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
    Lee MN; Kweon HY; Oh GT
    Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
    Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway.
    Kuo HP; Lee DF; Chen CT; Liu M; Chou CK; Lee HJ; Du Y; Xie X; Wei Y; Xia W; Weihua Z; Yang JY; Yen CJ; Huang TH; Tan M; Xing G; Zhao Y; Lin CH; Tsai SF; Fidler IJ; Hung MC
    Sci Signal; 2010 Feb; 3(108):ra9. PubMed ID: 20145209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer.
    Wang ZH; Gong JL; Yu M; Yang H; Lai JH; Ma MX; Wu H; Li L; Tan DY
    Asian Pac J Cancer Prev; 2011; 12(8):1973-7. PubMed ID: 22292636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
    Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
    Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein?
    Kuo HP; Hung MC
    Am J Transl Res; 2010 Jan; 2(1):56-64. PubMed ID: 20182582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.